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Germinal centers (GCs) are specialized microenvironments 
formed in the secondary lymphoid organs that generate 
high-affinity, long-lived antibody (Ab)-forming cells (AFCs) 
and memory B cells (Nutt and Tarlinton, 2011). GCs can 
spontaneously develop (spontaneously developed GCs [Spt-
GCs]) without purposeful immunization or infection (Lu-
zina et al., 2001; Cappione et al., 2005; Vinuesa et al., 2009; 
Wong et al., 2012; Hua et al., 2014; Jackson et al., 2014). We 
previously showed that in nonautoimmune B6 mice, Spt-
GCs contribute to steady-state Ab production while main-
taining B cell tolerance (Wong et al., 2012; Soni et al., 2014). 
Dysregulation of Spt-GC formation in human and mouse 
systemic lupus erythematosus (SLE) generates pathogenic 
antinuclear Ab (ANA)–specific IgG AFCs that lead to high 
titers of ANAs, the hallmark of SLE disease (Diamond et al., 
1992; Cappione et al., 2005; Wellmann et al., 2005; Vinuesa 
et al., 2009; Tiller et al., 2010; Kim et al., 2011). Autoreac-
tive B cells in Spt-GCs arise because of poor maintenance 
of B cell tolerance at the GC checkpoint, a factor that is an 
integral component of SLE disease initiation (Vinuesa et al., 
2009; Rahman, 2011). However, the pathway that promotes 
the aberrantly regulated Spt-GC response in SLE is not clear.
In human and mouse SLE, IFN-γ expression strongly 
correlates with disease severity (Pollard et al., 2013). IFN-γ 
deficiency or blockade reduces auto-Ab production and ame-
liorates renal disease in both MRL/MpJ-Faslpr and NZW/
NZBF1 lupus mice (Jacob et al., 1987; Ozmen et al., 1995; 
Balomenos et al., 1998; Haas et al., 1998; Schwarting et al., 
1998; Lawson et al., 2000), whereas excessive T cell–intrinsic 
IFN-γ signaling caused by decreased Ifng mRNA decay 
drives the accumulation of follicular T helper cells (Tfh cells) 
and subsequent Spt-GC and auto-Ab formation in mice ho-
mozygous for the san allele of Roquin (sanroque-Rc3h1san; 
Lee et al., 2012). Increased production of IFN-γ has been 
reported in SLE patients (Csiszár et al., 2000; Harigai et al., 
2008). Polymorphisms in the IFNG gene that drive increased 
IFN-γ expression are associated with SLE susceptibility (Kim 
et al., 2010). Also, blockade of IFN-γ has been shown to nor-
malize IFN-regulated gene expression and serum CXCL10 
in SLE patients (Welcher et al., 2015), highlighting the im-
portance of IFN-γ receptor (IFN-γR) signaling in SLE de-
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velopment. However, a B cell–intrinsic mechanism by which 
IFN-γ−IFN-γR signaling may drive Spt-GC development, 
leading to lupus-like autoimmunity, has not been described.
Lupus-prone B6.Sle1b mice develop larger and poorly 
regulated Spt-GCs as a result of altered B cell selection at 
the GC tolerance checkpoint (Wong et al., 2012, 2015). This 
altered GC checkpoint is driven by lupus-associated signaling 
lymphocyte activation molecule family genes (Wandstrat et 
al., 2004; Wong et al., 2015). Correspondingly, B6.Sle1b fe-
male mice exhibit significantly higher numbers of Spt-GC B 
cells and Tfh cells that promote elevated ANA titers (Wong et 
al., 2012, 2015). Consistent with other lupus models (Walsh 
et al., 2012; Hua et al., 2014; Jackson et al., 2014; Soni et al., 
2014), we recently reported a B cell–intrinsic requirement 
for TLR7 and MyD88 signaling in Spt-GC development 
and subsequent autoimmunity in B6.Sle1b mice (Soni et al., 
2014). The B cell–intrinsic mechanism by which IFN-γR 
signaling may promote Spt-GC development in B6.Sle1b 
mice or other autoimmune-prone mice is unknown.
In this study, we first used the B6 model of Spt-GC for-
mation to study the role and mechanisms by which IFN-γR 
and STAT1 signaling may control the Spt-GC response with-
out the confounding effects of any autoimmune susceptibility 
genes. We found that B cell–intrinsic IFN-γR expression is 
essential for Spt-GC development, indicating that IFN-γ sig-
naling serves as a novel GC initiation or maintenance factor. 
The reduction in Spt-GC response in B6.IFN-γR1−/− mice 
correlated with a decrease in IgG-producing AFCs and lower 
IgG, IgG2b, and IgG2c Ab titers compared with B6 control mice. 
We performed a thorough analysis of B cell–intrinsic mecha-
nisms of IFN-γR and STAT1 signaling that control Spt-GC 
formation. We found that IFN-γR signaling in B cells controls 
Spt-GC and Tfh cell development through STAT1-mediated 
and T-bet–dependent IFN-γ production by B cells. Subse-
quently, we determined how IFN-γR signaling might contrib-
ute to Spt-GC and Tfh cell responses in autoimmune-prone 
B6.Sle1b mice, leading to autoimmunity. Similar to the results 
obtained in the B6 model, we found significantly reduced 
Spt-GC and Tfh cell responses in B6.Sle1b.IFN-γR1−/− mice 
and in BM chimeric mice in which B6.Sle1b B cells lacked 
IFN-γR. The reduction in Spt-GC responses in both of these 
mice led to diminished ANA reactivity and significantly lower 
ANA-specific IgG AFCs and ANA titers than in B6.Sle1b mice. 
Finally, using an adoptive B cell transfer system, we showed a 
defect in proliferation and differentiation of DNA-reactive B 
cells into a GC phenotype in the absence of IFN-γR signaling 
in B cells. Together, our data delineate a previously unappreci-
ated B cell–intrinsic mechanism of IFN-γ signaling in driving 
Spt-GC development and autoimmunity.
RES ULTS
IFN-γ–IFN-γR signaling is essential for Spt-GC B cell 
and Tfh cell development
Given the role of IFN-γ signaling in promoting IgG Ab 
production (Pollard et al., 2013), we asked whether IFN-γ 
signaling is involved in Spt-GC development. We found 
that B6 mice deficient in IFN-γR1 (B6.IFN-γR1−/−) had 
significantly reduced percentages of B220+PNAhiFashi GC 
B cells and CD4+PD1hiCXCR5hi Tfh cells than wild-type 
B6 mice (Fig. 1, A and B). Immunohistochemical labeling 
of IgD−PNA+ GC B cells revealed an absence of Spt-GC 
formation in the spleens of B6.IFN-γR1−/− mice (Fig. 1 C). 
Additionally, the B220+ B cell population in B6.IFN-γR1−/− 
mice showed significantly reduced expression of the acti-
vation marker CD86 (Fig. 1 D). B6.IFN-γR1−/− mice also 
had a significantly lower number of IgG-producing AFCs 
than wild-type B6 mice, but IgM-producing AFCs were not 
significantly different between the two groups (Fig. 1, E and 
F). Similar results were seen in IFN-γ–deficient B6 mice (not 
depicted). The reduction in Spt-GC and IgG AFC responses 
translated to decreased levels of total IgG (Fig. 1 G), IgG2b 
(Fig. 1 I), and IgG2c (Fig. 1 J) in sera from B6.IFN-γR1−/− 
mice compared with control B6 mice. No significant differ-
ences were observed in IgG1 (Fig. 1 H) or IgM (Fig. 1 K) 
serum titers. Together, these data indicate that IFN-γR sig-
naling is required for Spt-GC development and for the pro-
duction of IgG2b and IgG2c Abs.
IFN-γR deficiency does not alter primary B cell 
development or foreign antigen–induced GC (iGC), 
Tfh cell, or Ab responses
Next, we evaluated whether the absence of Spt-GCs and signifi-
cantly reduced IgG2b and IgG2c Ab titers in B6.IFN-γR1−/− mice 
could be attributed to global defects in primary B cell develop-
ment and/or the ability of B cells to mount an immune response. 
To determine whether the lack of IFN-γR expression altered 
BM B cell development, we analyzed subpopulations of the early 
B cell progenitors and found no significant difference in fractions 
A–F (Hardy et al., 1991) between the two groups (Fig. 2, A and 
B). We also did not observe any significant differences in periph-
eral immature B cells, including transitional type 1, type 2, and 
type 3 as well as mature B cell populations, including follicular 
and marginal zone B cells in the spleen (Fig. 2, C and D; Allman 
et al., 2001). B6.IFN-γR1−/− mice did not show an alteration in 
surface expression of B cell maturation markers IgD, MHC II, 
IgM, or CD23 compared with B6 control mice (Fig. 2, E–H).
To study whether IFN-γR signaling is involved in for-
eign antigen iGC, Tfh cell, and AFC responses, we evaluated 
the B cell immune response against the T cell–dependent an-
tigen NP-CGG (4-hydroxy-3-nitrophenylacetyl–conjugated 
chicken γ-globulin) 14 d after immunization. We observed not 
a lower but rather a higher proportion of NP-specific GC B 
cells in B6.IFN-γR1−/− mice than B6 control mice (Fig. 3 A). 
We also observed no differences in NP-specific IgG and IgG1 
AFCs (Fig. 3, C and D) nor anti-NP IgG and IgG1 Ab responses 
(Fig. 3, E and F) between B6 and B6.IFN-γR1−/− mice. The 
percentage of Tfh cells in B6 mice was also not different from 
B6.IFN-γR1−/− mice (Fig. 3 B). Together, these data indicate that 
IFN-γR signaling is not involved in the foreign antigen–driven 
GC, Tfh cell, and AFC responses nor primary B cell development.
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IFN-γR signaling drives Spt-GC development in a 
B cell–intrinsic manner
To determine whether the requirement of IFN-γR signaling in 
the formation of Spt-GCs is B cell intrinsic, we first compared 
IFN-γR expression between B cells and T cells and found that 
IFN-γR surface expression was higher in B cells than in T cells 
(Fig. 4 A), with IFN-γR expression being significantly higher 
in B220+PNAhiFashi Spt-GC B cells than in B220+ non-GC B 
cells (Fig. 4 A). In contrast, IFN-γR expression on Tfh cells was 
significantly lower than naive T cells and B cells (not depicted).
Figure 1. IFN-γR signaling is required for Spt-GC formation and IgG production. (A and B) The percentages of B220+FashiPNAhi GC B cells (A) and 
CD4+CXCR5hiPD-1hi Tfh cells (B) were obtained from flow cytometric analysis of spleen cells of 3- and 6-mo-old B6 and B6.IFN-γR1−/− mice. Each symbol 
represents a mouse (n = 11–15). (C) Representative histological images of spleen sections from 6-mo-old mice (n = 5 per group) stained with the GC B cell 
marker PNA and anti-IgD. Bars, 150 µm. (D) Flow cytometric analysis of CD86 expression (MFI) on total B220+ B cells at 3 and 6 mo of age (n = 5 mice per 
group). Error bars are mean ± SD. (E and F) Numbers of IgG+ (E) and IgM+ (F) splenic AFCs in 6-mo-old mice of indicated strains (n = 5–9). (G–K) Analysis of 
serum titers of IgG, IgG1, IgG2b, IgG2c, and IgM Abs in 6-mo-old mice by ELI SA. Each symbol represents a mouse (n = 6–8). The data shown are the cumulative 
results of two or three independent experiments. Statistical values were determined using an unpaired, nonparametric, Mann–Whitney Student’s t test. 
Horizontal lines indicate mean values. *, P < 0.05; **, P < 0.01; ****, P < 0.001.
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Figure 2. IFN-γR signaling in B cell development. (A) Flow cytometric analysis of isolated BM populations for B cell developmental fractions A 
(B220+CD43+HSA−BP-1−), B (B220+CD43+HSA+BP-1−), and C (B220+CD43+HSA+BP-1+). HSA, heat-stable antigen. (B) Flow cytometric analysis of isolated BM 
populations for B cell developmental fractions D (B220+CD43−IgM−CD93+), E (B220+CD43−IgM+CD93+), and F (B220+CD43−IgM+CD93−) with plotted values 
for each fraction shown. (C) Flow cytometric analysis of isolated splenocyte populations for B cell developmental stages T1 (B220+AA4.1+CD23−IgM+), T2 
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Next, combinations of mature naive B cells and T 
cells were transferred from B6 or B6.IFN-γR1−/− mice into 
Rag1−/− mice (Fig. 4, B and C). Rag1−/− mice that received 
IFN-γR–deficient B cells and B6 T cells failed to develop 
Spt-GCs as evaluated by histology (Fig.  4, B and C, sec-
ond column). These mice also had significantly reduced 
numbers of IgG+ AFCs compared with B6 B cell and B6 
T cell combinations as controls (not depicted). In con-
trast, Spt-GCs were formed in Rag1−/− mice that received 
IFN-γR–deficient T cells and B6 B cells (Fig. 4, B and C, 
third column), highlighting the importance of IFN-γR ex-
pression on B cells in Spt-GC development. To confirm the 
B cell–intrinsic role of IFN-γR signaling in Spt-GC forma-
tion, we generated mixed BM chimeras by reconstituting 
lethally irradiated B6.μMT mice, which lack mature B cells, 
with a mixture of BM cells (80% derived from B6.μMT 
mice and 20% derived from either B6 or B6.IFN-γR1−/− 
mice). BM-reconstituted mice were rested for 3 mo before 
analysis. Mice reconstituted with IFN-γR–deficient BM 
cells exhibited significantly reduced percentages of B220+ 
PNAhiFashi GC B cells and CD4+PD1hiCXCR5hi Tfh cells 
than mice reconstituted with B6 BM cells as measured 
by flow cytometry (Fig.  4, D and E). Consistent with the 
flow cytometry data, spleens from recipients of IFN-γR–
deficient BM cells exhibited a significantly reduced num-
ber and size of IgD−GL7+ Spt-GCs (Fig.  4  F). These data 
demonstrate that IFN-γR expression on B cells is required 
for Spt-GC development.
IFN-γ–mediated T-bet expression and IFN-γ production by 
B cells are critical for Spt-GC development
Previous studies have identified the role of T-bet in IFN-γ–mediated 
IgG2a class switching (Peng et al., 2002; Xu and Zhang, 2005; 
Rubtsova et al., 2013). We therefore asked whether T-bet was 
involved in the development of Spt-GCs. We first exam-
ined T-bet expression in B cells and found that T-bet RNA 
(Fig. 5 A) and protein (Fig. 5 B) expression were significantly 
higher in Spt-GC B cells than in non-GC B cells and foreign 
antigen (NP-OVA) iGC B cells. No significant difference was 
observed between non-GC and iGC B cell T-bet expression 
(Fig. 5, A and B). The increased T-bet expression in Spt-GC B 
cells was associated with increased IFN-γ production by these 
cells compared with non-GC B cells (Fig. 5, C and D). During 
Spt-GC development, IFN-γ expression in vivo was signifi-
cantly higher in pre-Tfh cells than naive T cells (Fig. 5 E). How-
ever, IFN-γ expression was down-regulated in GC Tfh cells to 
levels similar to naive T cells (Fig. 5 E). Spt-GC and iGC B cells 
exhibited similar levels of Bcl-6 expression (not depicted).
To ask whether IFN-γ signaling drives T-bet expression 
and IFN-γ production by GC B cells, we used a 40LB fibro-
blast–based culture system (Nojima et al., 2011) to induce 
GC B cells ex vivo (see Materials and methods section In 
vitro GC B cell development assay). When these ex vivo–
generated GC B cells were cultured further for 4 d, their 
GC B cell phenotype could be maintained in the presence of 
either IL-4 or IFN-γ (Fig. 5 F). Treatment of these GC B cells 
with IFN-γ increased T-bet expression (Fig. 5, G and H) and 
IFN-γ production (Fig.  5  I), highlighting the role of T-bet 
and IFN-γ in maintaining the in vitro GC B cell phenotype. 
T-bet was not induced in and IFN-γ was not produced by 
these GC B cells in the presence of IL-4 (Fig. 5, G–I).
Finally, to evaluate the role of T-bet in Spt-GC forma-
tion in vivo, we analyzed T-bet–deficient B6 (B6.T-bet−/−) 
mice. B6.T-bet−/− mice had significantly reduced Spt-GC and 
Tfh cell responses than B6 mice at 3 mo of age (Fig. 6, A and 
B). Immunohistochemical labeling of IgD−GL7+ GC B cells 
revealed a significantly reduced size of Spt-GCs in the spleens 
of B6.T-bet−/− mice compared with B6 mice (Fig. 6 C). T-bet 
deficiency also strongly correlated with reduced IgG, IgG2b, 
and IgG2c serum Ab titers in B6.T-bet−/− mice (Fig. 6, D–F). 
By treating ex vivo–generated GC B cells from B6.T-bet−/− 
mice with IFN-γ, we further observed that the maintenance 
of the GC B cell phenotype (Fig. 6 G) and IFN-γ production 
by GC B cells (Fig. 6 H) were dependent on T-bet expression 
and IFN-γ production by these cells. Altogether, our data 
highlight the significance of T-bet expression and IFN-γ pro-
duction by B cells in driving Spt-GC development.
IFN-γR–mediated Spt-GC formation is STAT1 dependent
To determine mechanistically how IFN-γR signaling in B 
cells controls Spt-GC formation, we measured pSTAT1 
(pY701) and pSTAT3 (pY705) levels in B cells and found 
that B220+PNAhiFashi Spt-GC B cells had increased levels 
of STAT1, pSTAT1, and pSTAT3 compared with B220+ 
non-GC B cells (Fig. 7 A). Several studies using T cells have 
described STAT1-independent expression of T-bet and pro-
duction of IFN-γ (Ramana et al., 2002; Johnson and Scott, 
2007). Activation of both STAT1 and STAT3 by IFN-γ sig-
naling in acute myeloid leukemia cells was also previously 
reported (Sato et al., 1997). Therefore, we first determined 
whether IFN-γR signaling in B cells drove only STAT1 or 
both STAT1 and STAT3 phosphorylation. We treated puri-
fied naive B cells with IFN-γ in vitro and found a significant 
increase in pSTAT1 (Fig. 7 B) but not pSTAT3 (Fig. 7 C) 
within 5–15 min of IFN-γ treatment. By treating B cells with 
IFN-γ alone, anti-IgM alone, or IFN-γ plus anti-IgM, we 
(B220+AA4.1+CD23+IgM+), and T3 (B220+AA4.1+CD23+IgM−) with plotted values for each fraction shown. (D) Flow cytometric analysis of isolated splenocyte 
populations for marginal zone (MZ) B cells (B220+CD93−CD23−IgM+) and mature B cells (B220+CD93−CD23+IgM+) with plotted values for each fraction 
shown. Each symbol represents a mouse (n = 5–7). FO, follicular. (E–H) Plotted mean fluorescence intensity values show expression of IgD, MHC II, IgM, and 
CD23 on total splenic B220+ cells. Error bars are mean ± SD (n = 5 mice per group). Data represent two to three independent experiments. Statistical values 
were determined using an unpaired, nonparametric, Mann–Whitney Student’s t test.
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further observed that the IFN-γ–induced STAT1 phosphor-
ylation in naive B cells was independent of B cell receptor 
(BCR) stimulation (Fig. 7 D).
Finally, to study the role of STAT1 in Spt-GC develop-
ment, we analyzed B6 mice deficient in STAT1 (B6.STAT1−/−) 
for Spt-GC formation at 6 mo of age. B6.STAT1−/− mice had 
significantly reduced percentages of Spt-GC B cells and Tfh 
cells (Fig. 7 E) and had no Spt-GC formation in the spleen 
compared with B6 control mice (Fig. 7 F). To further study a 
B cell–intrinsic requirement of STAT1 in Spt-GC develop-
ment, we conditionally deleted STAT1 in B cells by crossing 
B6.STAT1flox/flox mice with CD19Cre mice (CD19CreSTAT1fl/fl). 
We found significantly lower GC and Tfh cell responses in 
CD19CreSTAT1fl/fl mice than in B6.STAT1flox/flox control mice 
(Fig. 7 G). Our histological analysis showed a lack of Spt-GC 
formation in CD19CreSTAT1fl/fl mice and well-formed GCs 
in B6.STAT1fl/fl control mice (Fig.  7  H), highlighting the 
significance of B cell–intrinsic IFN-γR and STAT1 signal-
ing in Spt-GC development. By treating ex vivo–generated 
STAT1-deficient GC B cells with IFN-γ, we observed that 
the maintenance of the GC B cell phenotype (Fig. 7 I), T-bet 
expression (Fig. 7 J), and IFN-γ mRNA expression (Fig. 7 K) 
by GC B cells were dependent on STAT1.
The critical B cell–intrinsic role of IFN-γR signaling in 
IFN-γR–mediated Spt-GC and auto-Ab responses
IFN-γR signaling is implicated in ANA production and 
Ab-mediated pathology in SLE disease (Pollard et al., 2013). 
Spt-GCs are likely a major source of autoreactive B cells, 
leading to auto-Ab production and the development of auto-
immunity (Diamond et al., 1992; Cappione et al., 2005; Well-
mann et al., 2005; Vinuesa et al., 2009; Tiller et al., 2010; Kim 
et al., 2011). To determine the role of IFN-γR signaling in 
the elevated Spt-GC response in SLE-prone mice, we crossed 
B6.IFN-γR1−/− mice to autoimmune-prone B6.Sle1b mice 
(named B6.Sle1b.IFN-γR1−/−). B6.Sle1b mice carry lupus- 
associated polymorphic signaling lymphocyte activation 
molecule family genes (Wandstrat et al., 2004). Correspond-
ingly, B6.Sle1b female mice exhibit an increased number of 
ANA-producing AFCs and high serum titers of ANAs as a 
result of significantly higher numbers of Spt-GC B cells and 
Tfh cells than wild-type B6 mice (Wong et al., 2012, 2015). 
We found that B6.Sle1b.IFN-γR1−/− mice had a signifi-
cantly reduced percentage of B220+PNAhiFashi GC B cells 
and CD4+PD1hiCXCR5hi Tfh cells compared with B6.Sle1b 
control mice (Fig.  8, A and B). The reduction of Spt-GC 
response in B6.Sle1b.IFN-γR1−/− mice was confirmed by 
immunohistochemical analysis, which revealed significantly 
smaller and fewer IgD−GL7+ GC structures in B6.Sle1b.
IFN-γR1−/− spleens compared with B6.Sle1b controls 
(Fig. 8 C). The number of splenic IgG+ and IgM+ AFCs was 
significantly reduced in B6.Sle1b.IFN-γR1−/− mice compared 
with B6.Sle1b controls (Fig. 8 D). A decrease in the number 
of long-lived IgM+ and IgG+ AFCs was observed in the BM 
of B6.Sle1b.IFN-γR1−/− mice compared with B6.Sle1b mice 
(Fig. 8 E). We also generated mixed BM chimeras by recon-
stituting lethally irradiated B6.μMT mice with a mixture of 
BM cells (80% derived from B6.μMT mice and 20% derived 
from either B6.Sle1b or B6.Sle1b.IFN-γR1−/− mice). Mice 
reconstituted with BM cells from B6.Sle1b.IFN-γR1−/− mice 
Figure 3. IFN-γR deficiency does not alter foreign an-
tigen iGC, Tfh cell, or AFC responses. (A and B) B6 (black 
circles) and B6.IFN-γR1−/− (gray circles) mice were immu-
nized with NP-CGG. Flow cytometric analysis was performed 
on splenocytes 14 d after immunization to obtain the per-
centages of B220+FashiPNAhi NP-specific GC B cells (A) and 
CD4+CXCR5hiPD-1hi Tfh cells (B). (C and D) Quantification of 
NP-specific IgG+ (C) and IgG1+ (D) AFCs by ELI SPOT assay in 
splenocytes obtained from these mice 14 d after immuniza-
tion. (E and F) Anti-NP IgG (E) and IgG1 (F) Ab titers are mea-
sured in sera obtained from mice described in A–D. These data 
represent seven to nine mice per group for all panels. Data 
are the cumulative results of two independent experiments. 
Statistical values were determined using an unpaired, non-
parametric, Mann–Whitney Student’s t test. *, P < 0.05.
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Figure 4. B cell–intrinsic requirement of IFN-γR signaling in Spt-GC and Tfh cell development. (A) Flow cytometric analysis of surface expres-
sion of IFN-γR on CD4+ T cells, B220+PNA−Fas− non-GC B cells, and B220+PNAhiFashi GC B cells. The mean IFN-γR surface expression (mean fluorescence 
intensity ± SD) in these three cell types from five mice of each genotype is shown in the right panel. Filled gray histogram indicates isotype control. 
(B) Representative images of spleen sections from Rag1−/− mice (five mice per group) that received combinations of naive B and T cells are shown. Sections 
were stained with anti-B220, anti-CD4, and GC B cell marker GL-7. Bottom panels show only GC B cell staining with GL-7. (C) Quantification of the number 
of GCs observed per 10× field from similar spleen sections shown in B (n = 5 mice per group). (D and E) The percentages of B220+FashiPNAhi GC B cells 
(D) and CD4+CXCR5hiPD-1hi Tfh cells (E) were obtained from flow cytometric analysis of spleen cells of 3-mo-old μMT mice reconstituted with BM cells from 
B6 and B6.IFN-γR1−/− mice. Each symbol represents a mouse (n = 3-4 mice per group). (F) Representative images of spleen sections from μMT mice (3–4 
mice per group) described in D and E are shown (left) in which sections were stained with GL-7, anti-IgD, and anti-CD4. The number of GCs observed per 
10× field from these mice (n = 3–4) is shown in the right panel. These data are representative of two independent experiments. In C, statistical analysis was 
performed by one-way ANO VA with a follow-up Tukey multiple-comparison test. In A, B, and D–F, statistical values were determined using an unpaired, 
nonparametric, Mann–Whitney Student’s t test. *, P < 0.05; **, P < 0.01; ****, P < 0.001. Bars,150 µm.
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exhibited significantly reduced percentages of GC B cells 
(Fig. 8 F, left) and Tfh cells (Fig. 8 F, right) than mice recon-
stituted with B6.Sle1b BM cells. Consistent with the flow 
cytometry data, spleens from recipients of IFN-γR–deficient 
B6.Sle1b BM cells exhibited a significantly reduced number 
and size of IgD−GL7+ Spt-GCs (Fig.  8 G). Together, these 
data suggest the B cell–intrinsic role of IFN-γR signaling in 
the dysregulated Spt-GC and Tfh cell responses in B6.Sle1b 
mice, leading to the accumulation of auto-Abs.
To determine the B cell–intrinsic role of IFN-γR 
signaling in driving the proliferation and differentiation of 
autoreactive B cells into GCs, we used a well-character-
ized adoptive transfer system that involves the transfer of p- 
azophenyl arsonate (Ars) and DNA dual-reactive heavy chain 
knock in (named HKIR) B cells into syngeneic CD45.1/
CD45.2 recipients preimmunized with Ars–keyhole limpet 
hemocyanin 1 wk before B cell transfer (Rahman et al., 2007; 
Vuyyuru et al., 2009; Wong et al., 2012). We performed a 
competition assay in which a mixture of Cell Trace–labeled 
2 × 105 CD45.1+ HKIR B cells and 2 × 105 CD45.2+ HKIR 
B cells deficient in IFN-γR1 (HKIR.IFN-γR1−/−) were trans-
ferred i.v. into Ars–keyhole limpet hemocyanin–immunized 
B6.CD45.1/45.2 recipients. 4 d after cell transfer, we ana-
lyzed HKIR B cell proliferation and GC B cell differentia-
tion into the GC phenotype. On average, 20% of transferred 
HKIR B cells actively proliferated as measured by Cell Trace 
dye dilution (Fig. 8 H). Notably, the proliferation of trans-
ferred HKIR.IFN-γR1−/− B cells was significantly lower than 
competing HKIR B cells in the same recipients (Fig. 8 H, 
right). In addition, a greater percentage of HKIR B cells 
differentiated into GC B cells (B220+PNAhiFashi) compared 
with HKIR.IFN-γR1−/− B cells (Fig. 8 I).
IFN-γR signaling promotes ANA development through the 
Spt–GC pathway in B6.Sle1b mice
Given the role of IFN-γR signaling in driving ANA-specific 
HKIR B cell proliferation and differentiation into the GC B 
cell phenotype (Fig. 8, H and I), we asked whether decreased 
Spt-GC and Tfh cell responses in B6.Sle1b.IFN-γR1−/− mice 
resulted in reduced ANA reactivity in these mice. Com-
pared with B6.Sle1b control mice, we found that B6.Sle1b.
IFN-γR1−/− mice had significantly lower numbers of dou-
ble-stranded DNA (dsDNA)–, histone-, and nucleosome- 
specific AFCs in both spleen (Fig. 9 A) and BM cells (long-lived 
AFCs; Fig. 9 B). Consistent with the AFC data, we observed 
a significant decrease in serum ANA positivity in B6.Sle1b.
Figure 5. Elevated T-bet expression and IFN-γ production by spontaneous GC B cells and IFN-γ–treated GC B cells. (A) Quantitative RT-PCR 
analysis of T-bet transcripts in B220+PNA−Fas− non-GC B cells, B220+PNAhiFashi Spt-GC B cells, and B220+PNAhiFashi iGC B cells analyzed at 14 d after NP-
OVA immunization. (B) Flow cytometric analysis of intracellular T-bet expression (by mean fluorescence intensity) in non-GC B cells, Spt-GC B cells, and 
iGC B cells. (C) Quantitative RT-PCR analysis of IFN-γ transcripts. BDL, below detectable level. (D) Flow cytometric analysis of intracellular IFN-γ production 
(by MFI) in non-GC B cells, Spt-GC B cells, and iGC B cells. (E) Flow cytometric analysis of intracellular IFN-γ levels in naive T cells (CD4+PD-1loCXCR5lo), 
pre-Tfh cells (CD4+PD-1intCXCR5int), and Tfh cells (CD4+PD-1hiCXCR5hi) during Spt-GC and iGC responses. (F) Maintenance of ex vivo–generated GC B cell 
phenotype in the presence of IFN-γ or IL-4. (G) Quantitative RT-PCR analysis of T-bet transcripts in GC B cells described in F. (H) Flow cytometric analysis of 
intracellular T-bet expression in GC B cells described in F. (I) Quantitative RT-PCR analysis of IFN-γ transcripts in GC B cells described in F. In all panels, data 
are representative of three replicate experiments with at least three mice per group. Statistical analysis was performed by one-way ANO VA with a follow-up 
Tukey multiple-comparison test. Error bars are mean ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.  on
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IFN-γR1−/− mice compared with B6.Sle1b mice as indicated 
by the fluorescence intensity of the nuclear staining on HEp-2 
slides (Fig. 9 C). In addition, we observed a decrease in nuclear 
antigen–specific seropositivity in B6.Sle1b.IFN-γR1−/− mice 
compared with B6.Sle1b mice (Fig. 9 C). To confirm the findings 
of the ANA positivity measured by Hep-2 assay and to measure 
isotype- and subclass-specific serum ANA titers, we performed 
ELI SA for specific nuclear antigens. B6.Sle1b.IFN-γR1−/− mice 
had a significant reduction in serum titers of IgG2b and IgG2c 
Abs specific for nucleosome, histone, and dsDNA than B6.Sle1b 
controls (Fig.  9, D–F). Reduced auto-Ab titers in B6.Sle1b.
IFN-γR1−/− mice correlated with a reduced glomerular nephritis 
score (Fig. 9 G). We also observed a significantly reduced number 
of total IgG AFCs (Fig. 9 H) as well as histone- and dsDNA- 
specific AFCs (Fig. 9, I and J) in chimeric mice in which B6.Sle1b 
B cells lacked IFN-γR compared with chimeric mice that re-
ceived B6.Sle1b BM cells. Consistent with the AFC data, we found 
diminished ANA reactivity in μMT mice receiving B6.Sle1b.
IFN-γR1−/− BM cells compared with B6.Sle1b control mice 
(Fig. 9 K). Together, these results suggest the B cell–intrinsic role of 
IFN-γR signaling in Spt-GC development and subsequent auto- 
Ab production, leading to kidney pathology in B6.Sle1b mice.
DIS CUS SION
B cells play a central role in SLE disease pathogenesis (Sanz, 
2014; Jackson et al., 2015). Therefore, understanding the 
Figure 6. Critical role of T-bet in Spt-GC development 
and Th1 Ab responses. (A and B) Percentages of B220+ 
FashiPNAhi GC B cells (A) and CD4+CXCR5hiPD-1hi Tfh cells 
(B) obtained from flow cytometric analysis of spleen cells of 
3-mo-old B6 and B6.T-bet−/− mice. Each symbol represents 
a mouse (n = 3–4). (C) Representative images of spleen 
sections from 3-mo-old B6 and B6.T-bet−/− mice stained 
with GL7, anti-CD4, and anti-IgD. GC area measurement 
is shown in the right panel (n = 3–4 mice per group). 
Bars, 150 µm. (D–F) Total serum Ab titers of IgG (D), IgG2b 
(E), and IgG2c (F) measured by ELI SA (n = 3–4 per group). 
(G) Maintenance of ex vivo–generated GC B cell phenotype 
of B6 and B6.T-bet−/− mice in media alone or with IFN-γ. 
(H) Quantitative RT-PCR analysis of IFN-γ transcripts in ex 
vivo–generated GC B cells (as described in G) from B6 and 
B6.T-bet−/− mice (n = 3–4 mice per group). The data shown 
in G and H are representative of three independent exper-
iments. In D–F, statistical analysis was performed by one-
way ANO VA with a follow-up Tukey multiple-comparison 
test. In A–C, G, and H, statistical values were deter-
mined using an unpaired, nonparametric, Mann–Whitney 
Student’s t test. Error bars are mean ± SD. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001; ****, P < 0.001.
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mechanisms that drive autoreactive B cell development would 
help specifically target these cells in treating SLE patients. 
Given the recently appreciated positive association of IFN-γ 
in SLE pathogenesis, in the current study, we determined 
the B cell–intrinsic role of IFN-γR signaling in promoting 
Spt-GC development and autoimmunity. Although it is not 
clear what triggers the development of Spt-GCs, our pub-
lished data indicate that both nonautoimmune B6 mice and 
autoimmune-prone B6.Sle1b mice develop Spt-GCs (Wong 
et al., 2012, 2015; Soni et al., 2014). We believe that the factor 
that triggers Spt-GC formation in B6 mice is identical to that 
observed in B6.Sle1b mice and is the basis for the dysregu-
Figure 7. B cell–intrinsic IFN-γR stimulus drives GC differentiation through STAT1, but not STAT3, phosphorylation. (A) Flow cytometric anal-
ysis of intracellular STAT1, pSTAT1, and pSTAT3 expression (by mean fluorescence intensity) in B220+PNA−Fas− non-GC B cells and B220+PNAhiFashi GC B 
cells. These data represent five mice per group in three replicate experiments. (B and C) Flow cytometric analysis of intracellular pSTAT1 (B) and pSTAT3 
(C) expression (mean fluorescence intensity) in B220+ cells after treatment of purified B cells with IFN-γ in vitro for the indicated time points. These data 
represent five mice per group in three replicate experiments. (D) Flow cytometric analysis of intracellular pSTAT1 expression (MFI) in B220+ cells with and 
without treatment of B cells with IgM alone, IFN-γ alone, or both IgM and IFN-γ in vitro for 10 min. These data represent five mice per group in three 
replicate experiments. (E) Flow cytometric analysis of percentages of B220+FashiPNAhi GC B cells and CD4+CXCR5hiPD-1hi Tfh cells in 6-mo-old mice. 
(F) Representative histological images of spleen sections from 6-mo-old B6 and B6.STAT1−/− mice (five mice per group) stained with the GC B cell marker 
GL7, anti-CD4, and anti-IgD. (G) Flow cytometric analysis of the percentages of GC B cells and Tfh cells. (H) Representative histological images and quantifi-
cation of GC structures of spleen sections from 3-mo-old B6.STAT1fl/fl and CD19Cre/+STAT1fl/fl mice (six mice per group). (I) Maintenance of ex vivo–generated 
GC B cell phenotype of B cells obtained from B6.STAT1fl/fl and CD19Cre/+STAT1fl/fl mice in the presence of IFN-γ. (J) Flow cytometric analysis of intracellular 
T-bet expression in GC B cells described in H. (K) Quantitative RT-PCR analysis of IFN-γ transcripts in GC B cells treated with IFN-γ as described in H. For 
H–J, n = 3 per group in three replicate experiments. In B and C, statistical analysis was performed by one-way ANO VA with a follow-up Tukey multiple-com-
parison test. Otherwise, statistical values were determined using an unpaired, nonparametric, Mann–Whitney Student’s t test. Error bars are mean ± SD. 
*, P < 0.05; **, P < 0.01; ***, P < 0.001. Bars: (F) 150 µm; (H) 75 µm.
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lated Spt-GC response caused by autoimmune susceptibility 
genes in B6.Sle1b mice and other lupus mice. Therefore, we 
first determined the B cell–specific role of IFN-γR signal-
ing in Spt-GC formation and Tfh cell development without 
the confounding effects of any autoimmune susceptibility 
genes by using the B6 model. We further demonstrated that 
IFN-γR and STAT1 signaling drive Spt-GC development 
through the expression of T-bet and the production of IFN-γ 
by B cells. Subsequently, we showed the B cell–intrinsic role 
of IFN-γR signaling in Spt-GC and Tfh cell responses in au-
toimmune-prone B6.Sle1b mice, leading to autoimmunity.
Spt-GCs can form in response to endogenous or 
self-antigens. In SLE-prone mice and SLE patients, altered 
regulation in the Spt-GC and Tfh cell responses helps gen-
erate somatically mutated pathogenic auto-Abs (Diamond et 
al., 1992; Cappione et al., 2005; Wellmann et al., 2005; Vinuesa 
et al., 2009; Tiller et al., 2010; Kim et al., 2011). We have pre-
viously shown that B cell–intrinsic, but not T cell-intrinsic, 
Figure 8. Reduced Spt-GC responses in global or B cell–specific IFN-γR–deficient autoimmune B6.Sle1b mice. (A and B) Percentages of B220+ 
FashiPNAhi GC B cells (A) and CD4+CXCR5hiPD-1hi Tfh cells (B) were obtained from flow cytometric analysis of spleen cells of 3- and 6-mo-old B6.Sle1b (n = 
10) and B6.Sle1b.IFN-γR1−/− mice (n = 10). (C) Representative images of spleen sections from 6-mo-old mice (five mice per group) stained with GL7, anti- 
CD4, and anti-IgD. GC area measurement (middle) and the quantification of the number of GCs per 10× field (right) are shown. (D) Quantification of IgG+ 
(left) and IgM+ (right) splenic AFCs in 6-mo-old mice (n = 10 mice per group). (E) Quantification of IgG+ (left) and IgM+ (right) BM AFCs in 6-mo-old mice (n = 
9 mice per group). (F) The percentages of B220+FashiPNAhi GC B cells (left) and CD4+CXCR5hiPD-1hi Tfh cells (right) were obtained from flow cytometric anal-
ysis of spleen cells from 3-mo-old B6.μMT mice reconstituted with BM cells from B6.Sle1b and B6.Sle1b.IFN-γR1−/− mice (four mice per group). (G) Repre-
sentative images of spleen sections from μMT mice (four mice per group) described in F are shown (left) in which sections were stained with GL-7, anti-IgD, 
and anti-CD4. The GC areas (randomly chosen 10 GCs per mouse) from the spleens of mice described in F are shown in the right panel. (H and I) Percentages 
of B6.HKIR and B6.HKIR.IFN-γR1−/− B cells undergoing proliferation (H) and GC B cell differentiation (I) in recipient mice. Where applicable, each symbol 
represents a mouse (n = 5 mice per group). The data shown are representative of three independent experiments. Statistical values were determined using 
an unpaired, nonparametric, Mann–Whitney Student’s t test. Error bars are mean ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.001. Bars, 150 µm.
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Figure 9. B6.Sle1b.IFN-γR1−/− mice exhibit reduced ANA titers and ANA-specific AFCs. (A and B) Quantification of dsDNA- (left), histone- (middle), 
and nucleosome- (right) specific AFCs in total splenocytes (A) and in BM cells (B) from indicated mouse strains (n = 7–10 mice per group). (C) ANA detection 
by fluorescent HEp-2 assay using sera from 6-mo-old mice (n = 5 mice per group). Representative images from five mice of each genotype are shown. 
Fluorescence intensity (gray values) of staining (right) and pie charts summarize the distribution of serum samples exhibiting nonreactivity (non–HEp-2 
 o
n
 June 6, 2016
jem.rupress.org
D
ow
nloaded from
 
Published April 11, 2016
727JEM Vol. 213, No. 5
expression of the lupus susceptibility locus Sle1b leads to el-
evated Spt-GC, Tfh cell, and auto-Ab responses in B6.Sle1b 
mice (Wong et al., 2012). Mutations in the Wiskott-Aldrich 
syndrome (Was) gene, a disease-associated allelic variant of 
protein tyrosine phosphatase nonreceptor 22 (Ptpn22) and 
Lyn deficiency, have also been shown to promote Spt-GC, 
Tfh cell, and autoimmune responses in a B cell–intrinsic man-
ner (Dai et al., 2013; Hua et al., 2014; Jackson et al., 2014). 
Alternatively, Lee et al. (2012) have reported that dysregulated 
Spt-GC and autoimmune responses in sanroque mice result 
from an accumulation of Tfh cells in a T cell–intrinsic man-
ner. Using the sanroque lupus model, Lee et al. (2012) showed 
that excessive IFN-γ production by T cells and T cell–intrinsic 
IFN-γ signaling profoundly increases Tfh cell accumulation 
and subsequent elevation of Spt-GC and auto-Ab responses. 
In this model, B cell–intrinsic IFN-γR deficiency did not sig-
nificantly affect the Spt-GC, Tfh cell, and auto-Ab responses. 
However, we find a B cell–intrinsic requirement of IFN-γR 
signaling in the formation of Spt-GCs and Tfh cells. This dif-
ferential B cell– and T cell–intrinsic role of IFN-γR signaling 
in Spt-GCs, Tfh cells, and autoimmunity may be attributed to 
two different models with distinct mechanisms for the loss of 
B cell tolerance, leading to SLE disease pathogenesis.
Using the B6.Sle1b model, we recently reported a B 
cell–intrinsic requirement of TLR7 in the formation of Spt-
GCs and class-switched auto-Abs (Soni et al., 2014). Other 
groups have confirmed the essential role of TLR7 in pro-
moting Spt-GC, Tfh cell, and auto-Ab responses (Walsh et al., 
2012; Hua et al., 2014; Jackson et al., 2014). Based on the role 
of BCR and TLR dual receptor signaling in autoimmune B 
cell activation (Leadbetter et al., 2002; Viglianti et al., 2003), 
synergistic BCR and TLR7 signaling are likely promoting 
Spt-GC, Tfh cell, and auto-Ab responses in lupus-prone mice. 
Interestingly, the absence of IFN-γR and STAT1 signaling 
also abrogates the development of well-formed Spt-GCs 
and auto-Ab generation in B6.Sle1b mice. The deficiency 
of TLR7 or IFN-γR signaling, however, does not signifi-
cantly affect the GC, Tfh cell, or Ab responses against T cell– 
dependent foreign antigens. Together, these data indicate that 
TLR7 and IFN-γR signaling in the development of Spt-GCs 
and autoimmunity are mechanistically distinct from foreign 
antigen–driven GC (iGC) and Tfh cell responses.
IL-21 secreted by GC Tfh cells is the major cytokine 
that controls GC and Tfh cell responses (Tellier and Nutt, 
2013). Previous studies showed a B cell–intrinsic role of 
IL-21 signaling in regulating GC and Ab responses elicited 
by protein immunization (Linterman et al., 2010; Zotos et 
al., 2010). Spt-GC responses were also significantly reduced 
in IL-21R–deficient MRL/MpJ-Faslpr mice (Rankin et al., 
2012). Recently, Bessa et al. (2010) described the B cell– 
intrinsic role of IL-21 and TLR (TLR7/8) signaling in the 
GC and Ab responses against virus-like particles loaded with 
bacterial RNA. We and other groups recently showed a B 
cell–intrinsic requirement of TLR7 and MyD88 signaling in 
the Spt-GC and Tfh cell responses (Walsh et al., 2012; Hua et 
al., 2014; Jackson et al., 2014; Soni et al., 2014). TLR stimu-
lation has been shown to be associated with increased IFN-γ 
production in T cells and myeloid cells (Chalifour et al., 2004; 
Caron et al., 2005). Our published data on the role of TLR7 
(Soni et al., 2014) and current findings about the role of 
IFN-γR signaling in the Spt-GC, Tfh cell, and auto-Ab re-
sponses in B6.Sle1b mice suggest that IFN-γR signaling may 
function downstream of TLR7 signaling, as TLR7 signaling 
can drive T-bet expression (Berland et al., 2006) and IFN-γ 
production in B cells. Although further studies are required 
to definitively determine the role of IFN-γR and IL-21R 
signaling at different stages of Spt-GC development, our data 
suggest that IFN-γR signaling in B cells is important in ini-
tiating Spt-GC formation.
Although the role of STAT1 and STAT3 signaling in B 
cell activation has recently been described in both mouse and 
human studies (Su et al., 1999; Xu and Zhang, 2005; Fornek 
et al., 2006; Avery et al., 2010), the role of STAT1 and/or 
STAT3 in IFN-γR–mediated Spt-GC development is not 
clear. We observed higher levels of pSTAT1 and pSTAT3 in 
Spt-GC B cells than non-GC B cells. By treating B cells ex 
vivo with IFN-γ, we showed only phosphorylation of STAT1 
and not of STAT3. These data indicate that STAT3 phosphor-
ylation is driven by a different pathway, such as by IL-21R, 
IL-6R, and IFN-αR signaling. Interestingly, we show an ab-
solute requirement of B cell–intrinsic STAT1 expression for 
Spt-GC development, indicating that STAT1 may be required 
for initiating the Spt-GC formation. STAT1 was previously 
shown to be required for IgG auto-Ab production and B cell 
expression of TLR7 in pristane-induced lupus mice (Thibault 
et al., 2008). STAT1 expression in MRL/MpJ-Faslpr mice was 
also associated with increased kidney nephritis and SLE-like 
disease (Dong et al., 2007). Recently, a lupus risk variant that 
reactive), reactivity to cytoplasmic antigens (cytoplasmic), reactivity to nuclear and cytoplasmic antigens (nuclear and cytoplasmic), and reactive to nuclear 
antigens only (nuclear). The numbers in the centers of the graphs denote the number of samples analyzed per group (bottom left). (D–F) Analysis of serum 
IgG2b and IgG2c Ab titers specific to nucleosome, histone, or dsDNA. Each symbol represents an individual mouse (n = 8–10 mice per group). (G) PAS-stained 
kidney sections of 6-mo-old female mice of each genotype (n = 5 mice per group) were analyzed for glomerular pathology. At least 100 glomeruli per 
mouse were individually scored for mesangioprolferative changes by a pathologist who was blinded to the sample genotypes. Error bars show mean ± SD. 
PAS, periodic acid–Schiff. (H–J) The numbers of IgG- (H), histone- (I), and ds-DNA– (J) specific AFCs in 3-mo-old B6.μMT mice reconstituted with BM cells 
from B6.Sle1b and B6.Sle1b.IFN-γR1−/− mice (four mice per group). (K) Detection of ANA reactivity by fluorescent HEp-2 assay in mice described in H–J. The 
data shown are representative of two or three independent experiments. In A–G, statistical analysis was performed by one-way ANO VA, with a follow-up 
Tukey multiple-comparison test. In H–K, statistical values were determined using an unpaired, nonparametric, Mann–Whitney Student’s t test. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001; ****, P < 0.001. Bars, 75 µm.
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is associated with decreased ETS1 and a high incidence of 
SLE has been shown to have increased pSTAT1 binding to 
DNA near the risk variant, spanning ETS1 gene in B cells (Lu 
et al., 2015). These data suggest that B cell–intrinsic IFN-γR 
and STAT1 signaling are crucial for Spt-GC development 
and autoreactive B cell selection in the GCs.
A combination of BCR, TLR7, and IFN-γR sig-
naling has been proposed to drive T-bet expression, which 
was shown to drive the expression of a recently described 
age-associated B cell phenotype and class switching to IgG2a 
and IgG2c Abs (Rubtsov et al., 2013; Rubtsova et al., 2013, 
2015). TLR7 signaling in RNA-specific 564Igi B cells has 
also been shown to drive T-bet expression and production 
of IgG2a and IgG2c Abs (Berland et al., 2006). How a syn-
ergy in BCR, TLR7, and IFN-γR signaling and T-bet ex-
pression in B cells may shape the Spt-GC response has not 
been described. In this study, we found that T-bet expression 
is significantly higher in Spt-GC B cells, which is, in turn, 
required for IFN-γ and IgG2c Ab production. By analyzing 
T-bet–deficient mice, we further showed that T-bet is criti-
cal for Spt-GC development. Although Spt-GC B cells and 
age-associated B cells share some common properties (i.e., 
increased expression of Fas and low expression of IgD), their 
lineage relationship remains to be defined. It will be interest-
ing to determine whether one population serves as a precur-
sor for the other population or whether they are two distinct 
B cell lineages with different functions.
Previous in vitro studies by Lund and co-workers have 
identified the molecular mechanisms that regulate IFN-γ 
production by B effector 1 (Be1) cells (Harris et al., 2005). 
IFN-γ production by Be1 cells is dependent on expression of 
the IFN-γR and the T-box transcription factor T-bet. Lund 
and co-workers also identified Be1 cells in mice infected with 
pathogens (i.e., Toxoplasma gondii or Heligmosomoides po-
lygyrus), which preferentially induce a type 1 immune re-
sponse (Harris et al., 2000). Differentiation of Be1 lineage cells 
into the GC B cell phenotype during spontaneous activation 
of B cells under nonautoimmune or autoimmune conditions 
has not been investigated. By performing mature B cell and 
T cell cotransfer as well as BM chimeric experiments, we 
discovered that IFN-γR expression on B cells is critical for 
Spt-GC and Tfh cell development. Compared with non-GC 
and iGC B cells, we observed higher T-bet expression in and 
IFN-γ production by Spt-GC B cells. We further demon-
strated that treatment of in vitro–generated GC B cells with 
IFN-γ drives T-bet expression, which promotes IFN-γ pro-
duction by GC B cells. Collectively, these data suggest a po-
tential differentiation of Be1 lineage cells into the Spt-GC B 
cell phenotype during spontaneous immune responses against 
endogenous ligand or self-antigen, which requires IFN-γR 
signaling, T-bet expression, and IFN-γ production by B cells.
In summary, we show that IFN-γR signaling in B cells 
and B cell IFN-γ production are the critical initial steps for 
Spt-GC development leading to autoimmunity. IFN-γR 
signaling controls Spt-GC formation by phosphorylating 
STAT1 and up-regulating T-bet in B cells, which is required 
for Spt-GC formation, IFN-γ production, and class switching 
to IgG2b and IgG2c Abs. Given our data on the B cell–intrinsic 
requirement of STAT1 in Spt-GC and Tfh cell development, 
we propose that in addition to its role in initiating Spt-GC 
formation by up-regulating T-bet expression and IFN-γ pro-
duction, STAT1 may target GC regulatory genes that pro-
mote the Spt–GC reaction. Together, we identify a novel B 
cell–intrinsic mechanism of IFN-γR and STAT1 signaling 
that is central to Spt-GC development leading to autoim-
munity. Because IFN-γR and STAT1 signaling are involved 
in SLE disease in both human and mouse models, targeting 
this pathway in Spt-GCs would be a promising treatment 
option for SLE disease.
MAT ERI ALS AND MET HODS
Mice. C57BL/6J (B6), B6.Ifngr1−/− (B6.IFN-γR1−/−), 
B6.129S-Stat1tm1Div/J (B6.STAT1−/−), B6.129-Stat1tm1Mam/
Mmjax (B6.STAT1fl/fl), B6.Cd19Cre/Cre, B6.129S7-Rag1tm1Mom/ 
J (Rag1−/−), B6.129S2-Ighmtm1Cgn/J (B6.μMT), B6.Tbx21−/− 
(B6.T-bet−/−), and B6.Ifng−/− (B6.IFN-γ−/−) mice were 
originally purchased from The Jackson Laboratory and bred 
in house. The development of B6 mice congenic for the 
Sle1b sublocus (named B6.Sle1b) and B6.HKIR mice were 
described previously (Wong et al., 2012). All animals were 
housed in the Pennsylvania State University Hershey Medical 
Center (PSU HMC) in a specific pathogen-free animal facil-
ity. All procedures were performed in accordance with the 
guidelines approved by the PSU HMC Institutional Animal 
Care and Use Committee.
Flow cytometry. Flow cytometric analysis of mouse spleno-
cytes or BM cells was performed using the following Abs: Pa-
cific blue–anti-B220 (RA3-6B2), Alexa Fluor 700–anti-CD4 
(RM4-5), PE-anti–PD-1 (29F.1A12), Cy5–anti-CD86 
(GL1), PeCy7–anti-CD95 (FAS, Jo2), PeCy7–anti-MHC 
II (M5/114.15.2), APC–anti-CD24 (HSA; M1/69), biotin– 
anti-Ly5.1 (BP-1; 6C3), FITC–anti-CD23 (B3B4), APC-
anti–T-bet (4B10), APC-anti–IFN-γ (XMG1.2), and PE–
Cy5-streptavidin (all purchased from BioLegend), as well as 
biotin–anti-CXCR5 (2G8), PE-anti–Bcl-6 (K112-91), and 
biotin–anti-CD119 (IFN-γR1, GR20; purchased from BD). 
FITC–peanut agglutinin (PNA) was purchased from Vector 
Laboratories. PE–anti-IgM (eB121-15F9), APC–anti-CD93 
(AA4.1), and FITC–anti-F4/80 (BM8) were purchased from 
eBioscience. The following Abs were used for phosphoflow 
analysis using a phosphoflow staining kit (BD): mouse anti- 
pSTAT1 (pY701; 4a), mouse anti-pSTAT1 (N terminus; 1/
Stat1), and mouse anti-pSTAT3 (pY705; 4/P-STAT3). For 
intracellular cytokines and transcription factor staining, cells 
were fixed and permeabilized using a cytoperm/cytofix kit 
(BD) and a FoxP3 staining buffer kit (eBioscience), respec-
tively. Stained cells were analyzed using a flow cytometer 
(LSR II; BD). Data were acquired using FAC SDiva software 
(BD) and analyzed using FlowJo software (Tree Star).
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Immunohistochemistry. Immunohistochemical labeling of 
mouse spleen sections was performed using the following Abs 
and reagents. For immunofluorescence, PE–anti-CD4 (GK1.5), 
FITC-GL7, and APC–anti-IgD (11-26c.2a; all from BD) 
were used. For visible histology, HRP–PNA (Sigma-Aldrich) 
and anti-IgD-biotin (11–26; SouthernBiotech) were used. 
Biotinylated Abs were detected by streptavidin–alkaline phos-
phatase (Vector Laboratories). Ab binding was detected using 
a blue alkaline–phosphatase substrate kit and the NovaRed 
kit for peroxidase (both from Vector Laboratories). 5–6-µm 
spleen cryostat sections were prepared as previously de-
scribed (Rahman et al., 2003).
Quantification of GC frequency and size by histology. Immu-
nohistochemistry was performed using the aforementioned 
Abs. Images of stained spleen sections were captured using a 
fluorescence microscope (DM4000; Leica Biosystems) and 
Leica Biosystems software. GC area was measured using an 
area measurement tool (LAS AF; Leica Biosystems). For GC 
frequency, total GC numbers were quantitated in five separate 
10× field areas per spleen section in a blinded manner.
ELI SPOT analysis. In brief, splenocytes in RPMI containing 
10% FBS were plated at a concentration of 106 cells per well 
onto anti-IgM–, anti-IgG–, salmon sperm dsDNA– (Invit-
rogen), calf thymus histone– (Sigma-Aldrich), or nucleo-
some- (histone plated on a layer of dsDNA coating) coated 
multiscreen 96-well filtration plates (EMD Millipore). Se-
rially diluted (1:2) cells were incubated for 6  h at 37°C. 
IgM-producing AFCs were detected using biotinylated 
anti–mouse IgM (Jackson ImmunoResearch Laboratories, 
Inc.) and streptavidin–alkaline phosphatase (Vector Labora-
tories). IgG-producing AFCs were detected using alkaline 
phosphatase–conjugated anti–mouse IgG (Molecular Probes). 
dsDNA-, histone-, and nucleosome-specific AFCs were de-
tected by biotinylated anti-κ Abs (Invitrogen) followed by 
streptavidin–alkaline phosphatase (Vector Laboratories) or 
alkaline phosphatase–conjugated anti–mouse IgG (Molecular 
Probes). Plates were developed using a blue alkaline phospha-
tase substrate kit (III; Vector Laboratories). ELI SPOTs were 
enumerated and analyzed using a computerized ELI SPOT 
plate imaging/analysis system (Cellular Technology).
ELI SA. For IgG or IgM detection, ELI SA plates (Thermo 
Fisher Scientific) were coated with anti-IgM or anti-IgG 
(both from Invitrogen) capture Abs and detected using bioti-
nylated anti–mouse IgM (Jackson ImmunoResearch Labora-
tories, Inc.) or alkaline phosphatase–conjugated anti–mouse 
IgG (Molecular Probes). Total IgG auto-Ab titers were mea-
sured in ELI SA plates coated with salmon sperm dsDNA (In-
vitrogen), histone (Sigma-Aldrich), or nucleosome (histone 
plated on a layer of dsDNA coating) and detected with bioti-
nylated anti-κ Abs (Invitrogen). IgG subtype–specific auto- 
Ab titers were detected by biotinylated IgG1, biotinylated 
IgG2b, and alkaline phosphatase IgG2c Abs (SouthernBio-
tech). Biotinylated Abs were detected by streptavidin–alkaline 
phosphatase (Vector Laboratories). The plates were devel-
oped by the PNPP (p-nitrophenyl phosphate, disodium salt; 
Thermo Fisher Scientific) substrates for alkaline phospha-
tase and read at 405 nm.
Immunizations. Mice were immunized i.p. with 200 µg/
mouse NP-CGG (Biosearch Technologies) in imject alum 
(Thermo Fisher Scientific) followed by a booster immu-
nization with 100 µg/mouse NP-CGG in alum 7 d later. 
Splenocytes were analyzed 14 d after initial immuni-
zation by flow cytometry.
Adoptive transfer. Magnetic-activated cell sorting (MACS)–
purified T cells and B cells were mixed at a 3:1 ratio (B cells/ 
T cells) and i.v. transferred into Rag1−/− recipients. Recipients 
were analyzed after 2 mo for Spt-GC and Tfh cell development.
Generation of BM chimeric mice. 10–12-wk-old female 
B6.μMT (B6.Ightm1Tim) mice recipients were lethally irradi-
ated with two doses of 450 rads of x rays (X-RAD 320iX 
Research Irradiator; Precision X-Ray) within a 4-h interval. 
Within 24 h of the second irradiation, each recipient i.v. re-
ceived 107 T cell–depleted BM cells isolated from 8–10-wk-
old female donor mice with 80% of cells from B6.μMT mice 
and 20% from B6 or B6.IFN-γR1−/− mice. In a similar exper-
iment, each B6.μMT recipient mouse i.v. received 107 T cell–
depleted BM cells isolated from 8–10-wk-old female donor 
mice with 80% of cells from B6.μMT mice and 20% from 
B6.Sle1b or B6.Sle1b.IFN-γR1−/− mice. Recipients were an-
alyzed after 3 mo for Spt-GC and Tfh cell development.
DNA/RNA preparation for real-time RT-PCR. Total RNA 
from different populations of B cells (naive B cells, Spt-GC B 
cells, iGC B cells, and ex vivo–generated GC B cells) was 
isolated as described previously (Wong et al., 2015). In brief, 
total RNA was isolated using a TRIzol reagent (Thermo 
Fisher Scientific) according to the manufacturer’s protocol. 
RT of the RNA was performed using a high-capacity RT kit 
(Applied Biosystems). Taqman PCR Master Mix kit or Power 
SYBR green PCR Master Mix kits were used to quantify 
gene expression (Applied Biosystems) using a real-time PCR 
system (StepOne Plus; Applied Biosystems). Primers for the 
bcl-6, Ifng, and tbx21 genes were synthesized by IDT Tech-
nologies. Primer sequences were as follows: Bcl-6, forward 
(5′-CTA GCG TCT GAC CAG GAT CCA-3′) and reverse (5′-
AGG TCA CGC TCA AGG TTT GC-3′); Ifng, forward (5′-
CGG CAC AGT CAT TGA AAG CC-3′) and reverse (5′-TGC 
ATC CTT TTT CGC CTT GC-3′); Tbx21, forward (5′-GCC 
AGG GAA CCG CTT ATA TG-3′) and reverse (5′-GAC GAT 
CAT CTG GGT CAC ATT GT-3′); and actin (Actb), which 
was used as the reference gene for sample normalization, for-
ward (5′-ATG TGG ATC AGC AAG CGG GA-3′) and reverse 
(5′-AAG GGT GTA AAA CGA AGC TCA-3′). cDNA was am-
plified under the following conditions for all primer sets: one 
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cycle at 95°C for 10 min followed by 40 cycles at 95°C for 
15 s and 60°C for 1 min.
In vitro B cell isolation, culture, and stimulation. Isolated 
splenocytes were cultured in RPMI 1640 (Gibco) containing 
10% FBS. To assay for cytokine production, splenocytes were 
cultured in GolgiStop (BD) and stimulated with phorbol 12- 
myristate 13-acetate (PMA) and ionomycin for 4 h at 37°C and 
5% CO2. After stimulation, B cells were processed for intracellu-
lar cytokine staining as described in the Flow cytometry section.
In vitro GC B cell development assay. Ex vivo GC B cells were 
generated according to a protocol described previously (No-
jima et al., 2011). In brief, 5 × 105 MACS-purified naive B cells 
(Miltenyi Biotec) were cultured in a 6-well plate (BD) over 
an adherent layer of 3–4 × 106 γ-irradiated (120 Gy) 40LB 
fibroblast cells. 40LB fibroblasts express CD40L and BAFF to 
stimulate B cell differentiation in the presence of IL-4. The 
culture media contained RPMI 1640 medium (Corning) 
supplemented with 10% FCS, β-ME (5.5 × 10−5 M), 10 mM 
Hepes, 1 mM sodium pyruvate, 100 U/ml penicillin, 100 µg/
ml streptomycin (Gibco), and 5 ng/ml rIL-4 (PeproTech). On 
the fourth day of culture, cells were harvested, washed, and 
analyzed for surface marker expression to confirm GC B cell 
phenotype and plated on another feeder layer of fibroblasts 
supplemented with media alone, rIL-4, or 10 ng/ml rIFN-γ 
(PeproTech) for another 4 d. On the eighth day of culture, 
cells were harvested and analyzed for surface marker expres-
sion by flow cytometry or processed for RNA preparation.
Phosphoflow analysis. For pSTAT kinetics experiments, 
MACS-purified B cells were activated with 5 μg/ml anti- 
IgM (Jackson ImmunoResearch Laboratories, Inc.) and/or 
10 ng/ml rIFN-γ (PeproTech) for the indicated time inter-
vals at 37°C. After activation, cells were fixed with a lyse/fix 
buffer (BD) for 10 min at 37°C. Cells were permeabilized 
with a perm/wash buffer (BD) for 30 min at room tempera-
ture. After two washes with a perm/wash buffer, cells were 
stained with anti-B220 and phosphoflow Abs (described in 
the Materials and methods section Flow cytometry; BD) for 
1 h at 4°C. For analysis of STAT staining in GC B cells, total 
splenocytes were fixed, permeabilized, and stained with anti- 
B220, anti-PNA, anti-CD95, and phosphoflow Abs.
HEp-2 ANA detection. For the detection of ANA seropositiv-
ity, sera from mice were incubated at a 1:50 dilution in PBS 
on HEp-2 ANA detection slides (Antibodies Inc.) and de-
tected with FITC–rat anti-κ (H139-52.1; SouthernBiotech).
Kidney histopathology. Kidneys from 6-mo-old females were 
fixed in 10% neutral buffered formalin and embedded in par-
affin. Kidney sections were cut at 3-µm thickness and periodic 
acid–Schiff stained. Pathology scores were obtained with a 
microscope (BX51; Olympus) and cellSens standard 1.12 im-
aging software (Olympus). A veterinary pathologist blinded 
to the genotype of the mice evaluated one kidney section per 
mouse. Each individual glomerulus was examined at 400× 
magnification and scored from 0 (normal) to 4 (severe) based 
on glomerular size and lobulation, presence of karyorrhectic 
nuclear debris, capillary basement membrane thickening, and 
the degree of mesangial matrix expansion/proliferation.
Statistical analysis. Comparisons of two groups were an-
alyzed using an unpaired, nonparametric, Mann–Whitney 
Student’s t test. One-way ANO VA, with a follow-up Tukey 
multiple-comparison test, was used to compare more than two 
groups. Prism 6 (GraphPad Software) was used for all analy-
ses. Wherever indicated, p-values are as follows: *, P < 0.05; 
**, P < 0.01; ***, P < 0.001; ****, P < 0.001. Bars reflect 
mean values, and error bars reflect standard deviation of the 
mean unless indicated otherwise.
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